Other aspects of management
| Phase I | Phase II | |
| Central venous pressure monitoring | ||
| All patients | 287/2332 (12.3%) | 298/1625 (18.3%)3-150 |
| High risk patients presenting with a systolic BP <70 or patients with concomitant cardiorespiratory disease and requiring blood transfusion | 126/421 (29.9%) | 129/299 (43.4%)† |
| Test of coagulation | ||
| All patients | 1294/2332 (55.5%) | 1055/1625 (64.9%)‡ |
| Patients with liver disease | 124/139 (89.2%) | 127/149 (85.2%) |
| Anticoagulated patients | 111/135 (82.2%) | 70/81 (86.4%) |
| Use of high dependency facility | ||
| All patients | 203/2322 (8.7%) | 146/1625 (9.0%) |
| High risk (initial risk score >2)10 | 127/1274 (10.0%) | 94/ 902 (10.5%) |
↵3-150 Increase, 6.0% (95% confidence interval (CI) 3.7% to 8.3%); †increase, 13.2% (95% CI 6.1% to 20.3%); ‡increase, 9.4% (95% CI 6.4% to 12.5%).
BP, blood pressure.